A meta-analysis encompassing 1308 adults and paediatric gliomas from 11 studies revealed that children aged 0 to 16 years old with a BRAF V600E mutation have a favourable prognosis, with a hazard ratio of 0.51 [52]. This evidence concerns the gene BRAF and glioma.